ClearBridge Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

ClearBridge Investments’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-512	Closed	-$1K	–	1134
2018 Q4	$1K	Hold	512	–	–	﹤0.01%	1119
2018 Q3	$4K	Hold	512	–	–	﹤0.01%	1099
2018 Q2	$2K	Sell	512 -700	-58%	-$3.24K	﹤0.01%	1112
2018 Q1	$5K	Hold	1,212	–	–	﹤0.01%	1057
2017 Q4	$4K	Hold	1,212	–	–	﹤0.01%	1086
2017 Q3	$5K	Hold	1,212	–	–	﹤0.01%	1126
2017 Q2	$6K	Buy	1,212 +50	+4%	+$281	﹤0.01%	1133
2017 Q1	$8K	Hold	1,162	–	–	﹤0.01%	1072
2016 Q4	$11K	Buy	1,162 +24	+2%	+$216	﹤0.01%	1075
2016 Q3	$11K	Hold	1,138	–	–	﹤0.01%	990
2016 Q2	$16K	Buy	1,138 +596	+110%	+$9.3K	﹤0.01%	958
2016 Q1	$8K	Buy	542 +162	+43%	+$2.38K	﹤0.01%	997
2015 Q4	$8K	Hold	380	–	–	﹤0.01%	1048
2015 Q3	$5K	Hold	380	–	–	﹤0.01%	1122
2015 Q2	$6K	Sell	380 -190	-33%	-$3.64K	﹤0.01%	1117
2015 Q1	$11K	Buy	+570	New	+$12.7K	﹤0.01%	1106

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ClearBridge Investments's AGTC Position: Q1 2019 in Review

ClearBridge Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2019, closing a stake of 512 shares — an estimated $1K sold.

ClearBridge Investments first reported a position in AGTC in Q1 2015 and held it in 16 quarters. The position peaked at $16K in Q2 2016. 50 funds tracked by Wall St. Rank hold AGTC as of Q1 2019.

ClearBridge Investments reported no remaining Applied Genetic Technologies Corporation position as of Q1 2019 after selling out during the quarter.
ClearBridge Investments sold 512 Applied Genetic Technologies Corporation shares in Q1 2019, an estimated $1K.
ClearBridge Investments first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 16 quarters.
ClearBridge Investments's Applied Genetic Technologies Corporation position peaked at $16K in Q2 2016.
50 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2019.

Based on ClearBridge Investments's 13F filing for Q1 2019, filed 15 May 2019.